Pacific Biosciences of California, Inc.
PACB· Nasdaq
PACBPacific Biosciences of California, Inc.
Released May 4, 2022, after the close
10-Q filed May 6, 2022, 36 days after period end · 0001299130-22-000053
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | $33.17M | $29.00M | $15.60M | $16.43M |
| Net Income | -$81.50M | -$87.44M | $1.26M | -$30.32M |
| EPS Diluted |
Pacific Biosciences of California, Inc. · CIK 1299130 · Engraved from SEC EDGAR
| -$0.37 |
| -$0.45 |
| $0.01 |
| -$0.20 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
